Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Mind Medicine (MindMed) Inc
Other
Mind Medicine (MindMed) Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Other
-$522k
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Other
-$105m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
13%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Other
-CA$21.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-22%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Other
CA$474k
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Other
-$10.2m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-74%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Other
-CA$6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-39%
|
|
Mind Medicine (MindMed) Inc
Glance View
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.
See Also
What is Mind Medicine (MindMed) Inc's Other?
Other
-522k
USD
Based on the financial report for Sep 30, 2025, Mind Medicine (MindMed) Inc's Other amounts to -522k USD.
What is Mind Medicine (MindMed) Inc's Other growth rate?
Other CAGR 3Y
-8%
The average annual Other growth rates for Mind Medicine (MindMed) Inc have been -8% over the past three years .
